This job has expired

You will need to login before you can apply for a job.

Associate Scientist, CRISPR Platform (Next Generation Sequencing)

Employer
Mammoth Biosciences
Location
Brisbane, CA
Start date
Jul 28, 2022

View more

You need to sign in or create an account to save a job.

Job Details

OPPORTUNITY
Mammoth is currently seeking a creative and detail-oriented Associate Scientist with expertise and experience in next generation sequencing (NGS) to join our CRISPR Platform team. The ideal candidate will work both cross-functionally with colleagues as well as independently to develop and execute NGS workflows to support the discovery, characterization, and development of novel Cas nucleases for genome editing.

The successful candidate will serve as the functional lead of the in-house NGS core and will also have the opportunity to contribute broadly across technical areas, such as high-throughput screening in mammalian cell lines and molecular biology/genomics process development. This is an excellent career opportunity for experienced researchers to contribute to development of cutting-edge CRISPR technologies.
KEY RESPONSIBILITIES
  • Develop and execute in-house NGS workflows (e.g. NGS library construction/QC, operating/maintaining in-house NGS instruments, timely data delivery, NGS user technical consultation)
  • Manage and sustain wet- and dry-lab operations of the in-house NGS core
  • Contribute to development of NGS-based assays to meet the technical needs across teams
  • Contribute to development and implementation of sample and data management tools
  • Detailed, accurate, and timely documentation of experimental procedures, data, and analysis, including meticulous sample tracking and data management

REQUIRED QUALIFICATIONS
  • Bachelor’s degree in molecular biology, genome sciences, biochemistry, or a related field and 4+ years experience or a Masters degree and 2+ years of experience of academic/industry research or laboratory operations related to next generation sequencing 

PREFERRED QUALIFICATIONS
  • Experience in applying NGS to answer research questions or solve scientific problems
  • Experience or proficiency in NGS sample preparation and data analysis
  • Working familiarity with quantification instruments such as Qubit, TapeStation, NanoDrop, qPCR machines, etc.
  • Experience working in an NGS or genomics core facility and operating Illumina sequencers (e.g. MiSeq, NextSeq)
  • Experience managing an NGS or genomics core facility (technical and/or people management)
  • Experience with high-throughput laboratory automation (e.g. Tecan liquid handlers, Echo, ZAG)
  • Experience or proficiency with SQL as well as data analysis tools such as JMP, R, etc.
  • 4+ years of biotechnology industry experience

BENEFITS
  • Company-paid health/vision/dental benefits
  • Unlimited vacation and generous sick time
  • Company-sponsored meals and snacks
  • Wellness, caregiver and ergonomics benefits
  • 401(k) with company matching

Mammoth Biosciences is harnessing the diversity of life to power the next generation of CRISPR products. Through the discovery and engineering of novel CRISPR systems, the company is enabling the full potential of its platform to read and write the code of life. Mammoth aims to develop permanent genetic cures through best-in-class in vivo and ex vivo therapies and to democratize disease detection with on-demand diagnostics. Mammoth can provide enhanced diagnostics and genome editing for life science research, healthcare, agriculture, biodefense and more. Based in the San Francisco Bay Area, Mammoth Biosciences is co-founded by CRISPR pioneer and Nobel Laureate Jennifer Doudna and Trevor Martin, Janice Chen, and Lucas Harrington. The firm is backed by top institutional investors including Redmile Group, Foresite Capital, Senator Investment Group, Sixth Street, Decheng, Mayfield, NFX, and 8VC, along with leading individual investors including Brook Byers, Tim Cook, and Jeff Huber.

TEAM
Our small-size proteins, such as Cas14 and CasPhi, are poised to transform disease treatment enabling novel editing approaches and delivery options that are difficult to achieve or not even possible with previously described CRISPR-Cas systems. Our teams are responsible for discovering and engineering novel CRISPR systems, establishing CRISPR-based diagnostics, and translating our unique CRISPR technology into therapeutic treatments with the ultimate goal of cures for indications with high medical need.

It is our policy and intent to provide equal opportunity to all persons without regard to race, color, religion, political affiliation, sex/gender (including gender expression/identity, pregnancy, childbirth and related medical conditions), marital status, registered domestic partner status, sexual orientation, age, ancestry, national origin, veteran status, disability, medical condition, genetic characteristics, and/or any other basis protected by law.  This policy covers all facets of employment including, but not limited to: recruitment, selection, placement, promotions, transfers, demotions, terminations, training, and compensation.

Mammoth Biosciences requires that all employees be vaccinated against COVID-19 as a condition of at-will employment, with exceptions for medical or religious reasons in compliance with local, state, and federal law. 

Company

Mammoth Biosciences is harnessing the diversity of nature to power the next generation of CRISPR products. Through its discovery of novel CRISPR systems, the company is enabling the full potential of its platform to read and write the code of life. With a distinguished team including co-founder and CRISPR-Cas genome editing co-inventor Jennifer Doudna, Mammoth is addressing challenges across healthcare, agriculture, environmental monitoring, biodefense, and more.

Facebook  Twitter  Instagram

Find Us
Website
Phone
(650) 294-8583
Location
South San Francisco
CA
94080
United States
You need to sign in or create an account to save a job.

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert